Fresenius SE & Co. KGaA (ETR:FRE)
Germany · Delayed Price · Currency is EUR 49.15
+0.34 (0.70%)
Nov 4, 2026, 9:46 AM CET
Fresenius SE & Co. KGaA Revenue
Fresenius SE & Co. KGaA had revenue of 5.95B EUR in the quarter ending June 30, 2026, with 5.22% growth. This brings the company's total for the last twelve months to 23.21B, up 4.08% year-over-year. In the year 2025, Fresenius SE & Co. KGaA had annual revenue of 22.87B with 4.19% growth. That makes Fresenius SE & Co. KGaA the 557th largest company in the world by revenue and 29th in Germany.
Revenue (ttm)
23.21B
Revenue Growth
+4.08%
P/S Ratio
1.18
Revenue / Employee
130.44K
Employees
178,486
Market Cap
27.68B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Fresenius SE & Co. KGaA breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.87B | 919.00M | 4.19% |
| Dec 31, 2024 | 21.95B | 887.00M | 4.21% |
| Dec 31, 2023 | 21.07B | -465.00M | -2.16% |
| Dec 31, 2022 | 21.53B | -15.99B | -42.61% |
| Dec 31, 2021 | 37.52B | 1.24B | 3.43% |
| Dec 31, 2020 | 36.28B | 868.00M | 2.45% |
| Dec 31, 2019 | 35.41B | 1.88B | 5.60% |
| Dec 31, 2018 | 33.53B | -356.00M | -1.05% |
| Dec 31, 2017 | 33.89B | 4.42B | 14.98% |
| Dec 31, 2016 | 29.47B | 1.48B | 5.27% |
| Dec 31, 2015 | 28.00B | 4.54B | 19.34% |
| Dec 31, 2014 | 23.46B | 3.13B | 15.39% |
| Dec 31, 2013 | 20.33B | 823.00M | 4.22% |
| Dec 31, 2012 | 19.51B | 3.15B | 19.23% |
| Dec 31, 2011 | 16.36B | 389.00M | 2.44% |
| Dec 31, 2010 | 15.97B | 1.81B | 12.76% |
| Dec 31, 2009 | 14.16B | 1.81B | 14.66% |
| Dec 31, 2008 | 12.35B | 995.00M | 8.76% |
| Dec 31, 2007 | 11.36B | 581.00M | 5.39% |
| Dec 31, 2006 | 10.78B | 2.89B | 36.61% |
| Dec 31, 2005 | 7.89B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Fresenius Medical Care AG | 19.43B |
| Sartorius Aktiengesellschaft | 3.66B |
| Drägerwerk AG & Co. KGaA | 3.59B |
| Fielmann Group AG | 2.46B |
| Carl Zeiss Meditec AG | 2.18B |
Fresenius SE & Co. KGaA News
- Just now - Fresenius SE & Co. KGaA Quarterly report: Q3 2026 - Filings
- Just now - Fresenius SE & Co. KGaA Slides: Q3 2026 - Filings
- Just now - Fresenius SE & Co. KGaA Earnings release: Q3 2026 - Filings
- 2 days ago - Fresenius and WuXi Biologics enter exclusive development agreement to expand biosimilars pipeline - PRNewsWire
- 6 days ago - Fresenius SE price target raised to EUR 59 from EUR 53 at Citi - TheFly
- 5 weeks ago - Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform - PRNewsWire
- 6 weeks ago - mAbxience, Sandoz sign collaboration agreement for biosimilar access - TheFly
- 2 months ago - Fresenius SE price target raised to EUR 52 from EUR 49 at Morgan Stanley - TheFly